Evidence map›Paper›PMID 41373758›Full record

ArticleInternational journal of molecular sciences2025

Red Blood Cell-Associated Features of Adenoviral Vector-Linked Venous Thrombosis.

Hanjin Park, Ok-Nam Bae, Sungbin Choi, Eunha Lee, Jun Chang, Han Young Chung

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hanjin ParkCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea.ORCID 0009-0003-3670-1896
Ok-Nam BaeCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea.ORCID 0000-0003-0583-2116
Sungbin ChoiCollege of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea.ORCID 0000-0002-9435-3434
Eunha LeeCollege of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0009-0009-2135-9569
Jun ChangGraduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
Han Young ChungCollege of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea.ORCID 0000-0003-0524-8278

Funding

BK21 FOUR Program (Chungnam National University Research Grant) 2025 (to H.Y.C.)Multi-Ministerial Research Program of Korea RS-2023-KH140699 (to O.-N.B.)National Research Foundation of Korea (NRF) RS-2023-00217123 (to O.-N.B.)National Research Foundation of Korea (NRF) RS-2025-00556716 (to H.Y.C.)
6 · The paper itself

Abstract

Adenoviral vector vaccines were pivotal for COVID-19 control, but postmarketing safety surveillance has identified venous-predominant thrombotic risks not fully explained by platelet-centric mechanisms. We tested an RBC-associated hypothesis using an Ad5 vector-rAd/HA(PR8) rat model within a predefined sub-hemolytic window (<10% hemolysis). Ex vivo, we quantified RBC surface phosphatidylserine (PS) exposure, morphology remodeling by scanning electron microscopy, and microvesicle generation, all aligning with increased procoagulant activity. RBCs also exhibited dose-dependent increases in thrombin generation 4 h after intravenous exposure (10

Indexed as

AdenoviridaeErythrocytesGenetic VectorsVenous ThrombosisAnimalsCOVID-19COVID-19 VaccinesDisease Models, AnimalHumansMalePhosphatidylserinesRatsSARS-CoV-2ThrombinCOVID-19 VaccinesPhosphatidylserinesThrombinadenoviral vector vaccinesadenovirus type 5 (Ad5)RBC shape changesred blood cellsthrombin generationvenous thrombosis

Identifiers

PMID41373758
PMCPMC12692020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.